Overview

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of dapsone gel versus vehicle control in patients with acne vulgaris.
Phase:
Phase 3
Details
Lead Sponsor:
Almirall, S.A.
MedDerm Associates
Collaborator:
Allergan
Treatments:
Dapsone